Today, FDA posted a notice announcing a change in its procedure for inspections of certain human drug compounders, which will take effect on August 1, 2016. FDA is making this change in response to stakeholder input.
Should you have questions, please contact us at compounding@fda.hhs.gov.
.png)
No hay comentarios:
Publicar un comentario